Evaluation and Management of Yellow Vaginal Discharge

Epidemiology & Differential Diagnosis

Yellow vaginal discharge most commonly reflects bacterial vaginosis, trichomoniasis, or mucopurulent cervicitis caused by Neisseria gonorrhoeae or Chlamydia trachomatis; pH testing and microscopic examination are required before initiating therapy. 1
Up to 50 % of women who meet clinical criteria for bacterial vaginosis are asymptomatic, highlighting the need for objective testing. 2
Trichomoniasis presents with a yellow‑green, frothy, malodorous discharge and is caused by Trichomonas vaginalis. 3
Mucopurulent cervicitis (MPC) produces a visible yellow endocervical discharge, yet most infected women lack overt MPC signs. 4
Non‑infectious vulvovaginal irritation (mechanical, chemical, or allergic) can cause minimal discharge with external vulvar inflammation and no detectable pathogens on microscopy. 2

A vaginal pH > 4.5 strongly suggests bacterial vaginosis or trichomoniasis, whereas a pH ≤ 4.5 is typical of candidiasis or physiologic discharge. 2

Saline wet mount: Diluting discharge in normal saline allows identification of motile T. vaginalis (trichomoniasis) or clue cells (bacterial vaginosis). 2
KOH preparation: Adding 10 % potassium hydroxide reveals yeast cells or pseudohyphae, confirming candidiasis. 2
Whiff test: A fishy amine odor after KOH application confirms bacterial vaginosis. 2
Culture for T. vaginalis is more sensitive than wet‑mount microscopy alone. 5

NAAT is required for definitive diagnosis of N. gonorrhoeae, C. trachomatis, and T. vaginalis because clinical presentation alone cannot reliably differentiate these pathogens. 2

Bacterial vaginosis: Oral metronidazole 500 mg twice daily for 7 days. 5
Mucopurulent cervicitis: Treat according to NAAT results or, in high‑prevalence settings, provide empiric therapy for both gonorrhea and chlamydia. 4
Male partners should not be treated for bacterial vaginosis, as partner therapy does not prevent recurrence. 5

Relying solely on symptoms leads to missed infections; up to 50 % of women with gonorrhea or chlamydia lack visible mucopurulent cervicitis. 2
Laboratory testing fails to identify the etiologic agent in a substantial minority of cases, necessitating clinical judgment. 5

Bacterial vaginosis accounts for a significant portion of vaginal discharge cases, presenting with homogeneous white-to-gray discharge, and is characterized by a fishy odor, though not all patients report this symptom, according to the Centers for Disease Control and Prevention 6
Normal vaginal discharge can be white or yellow, varies with the menstrual cycle, and is characterized by normal pH and absence of pathogens on microscopy, as stated by the American College of Obstetricians and Gynecologists 7

The American College of Obstetricians and Gynecologists recommends performing vaginal pH testing first to narrow the differential 7
If pH is elevated, it strongly suggests bacterial vaginosis or trichomoniasis, and the Centers for Disease Control and Prevention recommends performing a whiff test and examining saline wet mount for clue cells or motile trichomonads 6

The Centers for Disease Control and Prevention recommends treating bacterial vaginosis with oral metronidazole 500 mg twice daily for 7 days 6
The American Academy of Family Physicians recommends treating trichomoniasis with oral metronidazole 2 g as a single dose, and emphasizes the importance of simultaneous treatment of sex partners to prevent reinfection 8 9
The American College of Obstetricians and Gynecologists states that no treatment is required for physiologic discharge, and recommends reassurance and patient education 7

The American College of Obstetricians and Gynecologists advises against empirically treating for candidiasis without confirming the diagnosis, as the absence of itching makes this diagnosis unlikely 7
The Centers for Disease Control and Prevention warns against treating asymptomatic candidal colonization detected on culture, as this represents normal flora in a significant portion of women 10